Stella Wilson
Stories (15/0)
Gene Therapy Market 2021-2030
Gene Therapy Market is projected to grow at an annualized rate of 45%, till 2030 Encouraging clinical results across various metabolic, hematological and ophthalmic disorders have inspired research groups across the world to focus their efforts on the development of novel gene editing therapies. In fact, the gene therapy pipeline has evolved significantly over the past few years, with three products being approved in 2019 alone; namely Beperminogene perplasmid (AnGes), ZOLGENSMA® (AveXis) and ZYNTEGLO™ (bluebird bio).
By Stella Wilson3 years ago in Journal
Global Companion Diagnostics Development Services Market share will expand till 2030
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise.
By Stella Wilson3 years ago in 01
HPAPI and cytotoxic drugs contract manufacturing Market
The “HPAPI and Cytotoxic Drugs Manufacturing Market 2021-2030” report features an extensive study of the current market landscape, offering an informed opinion on the manufacturing of HPAPIs and cytotoxic drugs over the next decade.
By Stella Wilson3 years ago in Journal
Ophthalmic Drugs Contract Manufacturing Market by 2030
Roots Analysis has done a detailed study on Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
By Stella Wilson3 years ago in Journal
In Silico Drug Discovery Services Market is likely to be worth USD 124 million by 2030
Excessive capital requirement and myriad of other complexities associated with the discovery of biologics have prompted drug developers to adopt in silico tools / techniques to expedite the discovery timelines
By Stella Wilson3 years ago in Journal
Neoantigen Targeted Therapies Market 2030
Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential
By Stella Wilson3 years ago in Journal
Global Continuous Manufacturing Market and Industry Analysis Report by 2030
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing
By Stella Wilson3 years ago in Journal
Microbial Contract Biomanufacturing Market
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment
By Stella Wilson3 years ago in 01
T-cell immunotherapy market by 2030
Driven by high success rates in clinical trials and the potential to confer sustained periods of disease remission, T-cell therapies have received significant financial support, with approved products poised to soon achieve blockbuster status
By Stella Wilson3 years ago in Journal